DK146063C - METHOD OF ANALOGUE FOR THE PREPARATION OF METHYLAMINE DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS. - Google Patents

METHOD OF ANALOGUE FOR THE PREPARATION OF METHYLAMINE DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.

Info

Publication number
DK146063C
DK146063C DK244677A DK244677A DK146063C DK 146063 C DK146063 C DK 146063C DK 244677 A DK244677 A DK 244677A DK 244677 A DK244677 A DK 244677A DK 146063 C DK146063 C DK 146063C
Authority
DK
Denmark
Prior art keywords
analogue
preparation
acid addition
addition salts
acceptable acid
Prior art date
Application number
DK244677A
Other languages
Danish (da)
Other versions
DK146063B (en
DK244677A (en
Inventor
Charles Pigerol
Pierre Eymard
Jean-Claude Vernieres
Madeleine Broll
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DK244677A publication Critical patent/DK244677A/en
Priority to DK570881A priority Critical patent/DK146178C/en
Priority to DK571081A priority patent/DK146180C/en
Priority to DK570981A priority patent/DK146156C/en
Publication of DK146063B publication Critical patent/DK146063B/en
Application granted granted Critical
Publication of DK146063C publication Critical patent/DK146063C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK244677A 1976-06-03 1977-06-02 METHOD OF ANALOGUE FOR THE PREPARATION OF METHYLAMINE DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS. DK146063C (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DK570881A DK146178C (en) 1976-06-03 1981-12-22 METHOD OF ANALOGUE FOR THE PREPARATION OF METHYLAMINE DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.
DK571081A DK146180C (en) 1976-06-03 1981-12-22 METHOD OF ANALOGUE FOR THE PREPARATION OF METHYLAMINE DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.
DK570981A DK146156C (en) 1976-06-03 1981-12-22 METHOD OF ANALOGUE FOR THE PREPARATION OF METHYLAMINE DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE842528 1976-06-03
BE842528 1976-06-03

Publications (3)

Publication Number Publication Date
DK244677A DK244677A (en) 1977-12-04
DK146063B DK146063B (en) 1983-06-20
DK146063C true DK146063C (en) 1983-11-14

Family

ID=3861370

Family Applications (1)

Application Number Title Priority Date Filing Date
DK244677A DK146063C (en) 1976-06-03 1977-06-02 METHOD OF ANALOGUE FOR THE PREPARATION OF METHYLAMINE DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.

Country Status (17)

Country Link
JP (1) JPS6039261B2 (en)
AR (4) AR213646A1 (en)
AT (1) AT352088B (en)
AU (1) AU511705B2 (en)
DK (1) DK146063C (en)
ES (2) ES459466A1 (en)
FI (1) FI63015C (en)
FR (2) FR2374901A1 (en)
GR (1) GR61148B (en)
MX (1) MX4778E (en)
NL (1) NL7706052A (en)
NO (1) NO145337C (en)
NZ (1) NZ184161A (en)
PT (1) PT66623B (en)
SE (2) SE452317B (en)
YU (1) YU129577A (en)
ZA (1) ZA773151B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES437790A1 (en) * 1974-05-20 1977-05-16 Labaz Therapeutic compositions containing methylamine derivatives or their salts
BE842528R (en) * 1976-06-03 1976-12-03 METHYLAMINE ACTIVE DERIVATIVES, THERAPEUTIC COMPOSITIONS CONTAINING THEM AND THE PROCESSES FOR THE PREPARATION OF THESE DERIVATIVES AND COMPOSITIONS

Also Published As

Publication number Publication date
DK146063B (en) 1983-06-20
NL7706052A (en) 1977-12-06
DK244677A (en) 1977-12-04
NO145337C (en) 1982-03-03
FI63015B (en) 1982-12-31
GR61148B (en) 1978-09-27
FR2372795A1 (en) 1978-06-30
ZA773151B (en) 1978-04-26
YU129577A (en) 1983-01-21
SE452763B (en) 1987-12-14
PT66623B (en) 1978-11-07
SE452317B (en) 1987-11-23
JPS6039261B2 (en) 1985-09-05
AR215052A1 (en) 1979-08-31
NO145337B (en) 1981-11-23
ES470379A1 (en) 1979-10-16
SE8206445L (en) 1982-11-12
AU511705B2 (en) 1980-09-04
NO771941L (en) 1977-12-06
FR2372795B1 (en) 1983-08-12
PT66623A (en) 1977-07-01
AR215053A1 (en) 1979-08-31
MX4778E (en) 1982-09-15
SE8206445D0 (en) 1982-11-12
AR215175A1 (en) 1979-09-14
SE7706448L (en) 1977-12-04
JPS52148006A (en) 1977-12-08
ES459466A1 (en) 1978-08-16
ATA395877A (en) 1979-02-15
FI771780A (en) 1977-12-04
NZ184161A (en) 1980-10-08
AU2556177A (en) 1978-11-30
AT352088B (en) 1979-08-27
AR213646A1 (en) 1979-02-28
FR2374901A1 (en) 1978-07-21
FI63015C (en) 1983-04-11
FR2374901B1 (en) 1981-04-17

Similar Documents

Publication Publication Date Title
DK150512C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 3-QUINO-LINCARBOXYLIC ACID DERIVATIVES OR ACID ADDITION SALTS.
DK151623C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF N-SUBSTITUTED MORANOLINE DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.
DK149308C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF TRANS-4-PHENYL-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.
DK145339C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 4-AMINO-5-HEXENIC ACID OR PHARMACEUTICAL ACCEPTABLE SALTS THEREOF
DK149594C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF DIPEPTIDE DERIVATIVES OR ACID ADDITION SALTS
DK149895C (en) PROCEDURE FOR THE PREPARATION OF ALFA-AMINOACYLPROLYL-NG-CARBOXY ARGINALDEHYDE DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.
DK149022C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF AMINE DERIVATIVES OF DI-O- (N-ALKYL OR ALKENYL) -GYCEROLES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.
DK149111C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF HISTIDIN DERIVATIVES OR ACID ADDITION SALTS.
DK149449C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF CARBOSTYRIC DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE SALTS THEREOF
DK148904C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF ANALGETICALLY EFFECTIVE ENKEPHALIN ANALOGUE PENTAPEPTIDAMIDES OR PHARMACEUTICAL ACCEPTABLE NON-TOXIC ACID ADDITION SALTS THEREOF
DK146592C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF N-SUBSTITUTED BENZEN SULPHONAMIDS OR ACID ADDITION SALTS.
DK160045C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 4-OXO-4H-PYRIDOOE1,2-AAAPYRIMIDINES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS OR QUATERNARY AMMONIUM SALTS THEREOF
DK153157C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 7-ALFA-AMINOACYL-3-HALOGEN-CEPHALOSPORINE DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.
DK154950C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 1- (BENZAZOLYLALKYL) -PIPERIDE INGREDIENTS OR THE PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS
DK146281C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 2-BROMO-6-FLUORO-N-2-IMIDAZOLIDINYLIDE-BENZAMINE OR ACID ADDITION SALTS.
DK151805C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 20,21-DI-NOR-EBURNAMENIN DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ADDITIONAL SALTS THEREOF
DK149077C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF ENCEPHALIN ANALOGUE PENTAPEPTIDAMIDE DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS THEREOF
DK149841C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF ALFA-FLUOR-METHYL-ALFA AMINOALCANIC ACIDS OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.
DK145263C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF IMIDAZOTHIAZINES OR PHARMACEUTICAL ACCEPTABLE SALTS THEREOF
DK143105C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF AMINOBENZOCYCLOHEPTEND DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ADDITION SALTS THEREOF
DK144793C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF DIHYDRO OR TETRAHYDROIMINOTHIAZINES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS THEREOF
DK148281C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 8A-SUBSTITUTED 8,8A-DESOXY-8,8A-DIHYDROOLEANDOMYCINE COMPOUNDS OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.
DK157021C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 2,3-POLYMETHYLENE-4-OXO-4H-PYRIDO- OR -AZEPINOOE1,2-AAAPYRIMIDINES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS OR QUATERA SALTS
DK146886C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF BASIC SUBSTITUTED O-PROPYLED OXIMES OR PHYSIOLOGICALLY ACCEPTABLE ACID ADDITION SALTS.
DK152211C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF N-PHENYL-N- (4-PIPERIDINYL) -AMIDS OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.

Legal Events

Date Code Title Description
PBP Patent lapsed